Verastem Oncology在2026年妇科肿瘤学会(SGO)女性癌症年度会议上,公布了其Avmapki®与Fakzynja®联合疗法(即Avutometinib胶囊与Defactinib片剂)用于治疗复发性低级别浆液性卵巢癌的两年中位随访数据。
Verastem Oncology在2026年妇科肿瘤学会(SGO)女性癌症年度会议上,公布了其Avmapki®与Fakzynja®联合疗法(即Avutometinib胶囊与Defactinib片剂)用于治疗复发性低级别浆液性卵巢癌的两年中位随访数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.